Shin Nippon Biomedical LaboratoriesSHIN NIPPON BIOMEDICAL LABORATORIES, LTD.2395東証プライムサービス業FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥8 is left as operating profit. Revenue changed +0.3% from the prior year, operating profit -11.1%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 40.2% | 0.45× | 18.1% | 1.77× | 32.1% |
| 2023 | 24.2% | 0.52× | 12.6% | 2.01× | 25.3% |
| 2024 | 20.9% | 0.40× | 8.3% | 2.43× | 20.1% |
| 2025 | 15.2% | 0.38× | 5.8% | 2.75× | 16.0% |
| 2026 | 14.0% | 0.33× | 4.6% | 2.96× | 13.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 17,748 | 25,091 | 26,450 | 32,414 | 32,525 |
| Cost of revenue | 8,061 | 12,044 | 12,168 | 15,453 | 16,286 |
| Gross profit | 9,687 | 13,047 | 14,283 | 16,961 | 16,239 |
| SG&A | 5,492 | 7,801 | 10,120 | 13,976 | 13,585 |
| Operating income | 4,196 | 5,245 | 4,162 | 2,985 | 2,654 |
| Pretax income | 8,183 | 7,760 | 6,974 | 6,013 | 6,248 |
| Income tax | 1,016 | 1,709 | 1,457 | 1,149 | 1,713 |
| Net income attributable to owners | 7,128 | 6,060 | 5,531 | 4,925 | 4,567 |
| Operating margin | 23.6% | 20.9% | 15.7% | 9.2% | 8.2% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥4.55B | ¥9.2B | ¥10.3B | ¥11.8B | ¥18.4B |
| Total assets | ¥39.3B | ¥57.2B | ¥76.3B | ¥92.4B | ¥105.1B |
| Net assets | ¥19.7B | ¥26.4B | ¥34.2B | ¥40.1B | ¥43.5B |
| Share capital | ¥9.68B | ¥9.68B | ¥9.68B | ¥9.68B | ¥9.68B |
| Inventories | ¥4.36B | ¥7.33B | ¥12.4B | ¥12.6B | ¥15.1B |
| Property, plant and equipment | ¥13.2B | ¥18.9B | ¥26.4B | ¥34.8B | ¥36.2B |
| Intangible assets excluding goodwill | ¥212.3M | ¥1.7B | ¥2.16B | ¥2.1B | ¥2.12B |
| Goodwill | — | ¥1.44B | ¥1.93B | ¥1.88B | ¥1.76B |
| Investment securities | ¥7.08B | ¥12B | ¥15.2B | ¥19.8B | ¥21.4B |
| Current assets | ¥16.1B | ¥23.9B | ¥30.8B | ¥32.9B | ¥43B |
| Current liabilities | ¥13.4B | ¥21B | ¥23.6B | ¥29.3B | ¥39.3B |
| Trade payables | — | ¥419.8M | ¥460.5M | ¥460.9M | ¥406.9M |
| Short-term borrowings | ¥2.94B | ¥8.92B | ¥7.83B | ¥11.8B | ¥19.7B |
| Long-term borrowings | ¥5.81B | ¥9.48B | ¥18.1B | ¥22.3B | ¥21.1B |
| Total liabilities | ¥19.6B | ¥30.9B | ¥42.1B | ¥52.3B | ¥61.6B |
| Non-controlling interests | ¥162M | ¥147.2M | ¥46.2M | ¥62.9M | ¥368.5M |
| Equity attributable to owners of parent | ¥22.2B | ¥25.8B | ¥29.3B | ¥32.1B | ¥34.6B |
| Retained earnings | ¥10.2B | ¥13.8B | ¥17.2B | ¥20.1B | ¥22.6B |
| Treasury stock | -¥247K | -¥420K | -¥420K | -¥745K | -¥780K |
EDINET (FSA Japan)
有価証券報告書－第53期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第52期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第51期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第50期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第49期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第48期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 55 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.